Position in LQDA
as of Mar 31, 2026
· filed Apr 22, 2026
Position Value
$246,630
New position
Shares Held
6,535
first reported quarter
Ownership
0.007%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Apollon Wealth Management, LLC holds $10,905,872 across 10 Drug Manufacturers - Specialty & Generic names. LQDA ranks #5 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
13,288 | $7,879,518 | |
| 2 | ZTS |
Zoetis Inc.
|
15,247 | $1,802,347 | |
| 3 | VTRS |
Viatris Inc
|
21,628 | $292,194 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
8,226 | $247,767 | |
| 5 | LQDA |
Liquidia Corp
This page
|
6,535 | $246,630 | |
| 6 | HLN |
Haleon plc
|
21,271 | $212,922 | |
| 7 | TLRY |
Tilray Brands, Inc.
|
14,761 | $95,503 | |
| 8 | CRON |
Cronos Group Inc.
|
21,924 | $55,029 |
All Filings in LQDA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $246,630 | 6,535 | Shares | Sole | 2026-04-22 | |
| No filing history on record for this holder in this stock. | ||||||